Donaire, Ricky Jr G.

HRN: 26-74-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2025
CEFTRIAXONE 1G (VIAL)
02/21/2025
02/28/2025
IV
2g
Q12H
T/C Acute Leukemia / Hyperleukocytosis
Waiting Final Action 
02/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/22/2025
03/01/2025
IV
240 Mg
Q 8 Hours
UTI
Waiting Final Action 
02/23/2025
CEFTAZIDIME 1GM (VIAL)
02/23/2025
03/02/2025
IV
2g
Q 8 Hours
T/C Tumor Lysis Syndrome
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: